GEN Roundup: No Detail Is Too Small in Bioprocess Scaleup
A Change in Scale Can Change Everything
Amid Election Clamor, Research Issues Surface
Sounds of Science Podcast
10 Takeover Targets of 2016
Which Biopharmas Do Wall Street Watchers View As Top Buyout Candidates?
Molecular Dx Has Your (Copy) Number
CNV Detection and Analysis Tools Are Being Used To Fill Genetic Diagnostic Gaps
Genome Sequencing and Patient Autonomy
In a dramatic shift away from the patient’s “right-not-to-know” message pervading clinical genetics since the field’s inception, new guidelines issued by American College of Medical Genetics and Genomics suggest that anyone undergoing genome sequencing for any reason should also be screened for dozens of variants associated with life-threatening but treatable conditions. (Read more about the new guidelines here.) What are your thoughts on this?